Repligen Corp. (RGEN)$115.06
Market Cap: 7.92 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Repligen Corp. (RGEN).
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
DCF ready
Valuation
84.1x
EV/FCF, 1.2% FCF yield
Quality
1.8%
ROIC, N/A FCF margin
Growth
N/A
5Y sales (revenue) CAGR
Balance sheet
0.3x
Debt/equity, 8.4x current ratio
Superinvestors
2
Top: Lee Ainslie (2.1%)
Strengths to research
- Free cash flow compounded at 18.5% over five years.
- Debt/equity looks manageable at 0.3x.
- 10 annual periods are available for trend analysis.
Watchouts
- P/E is elevated at 133.8x.
- P/FCF is elevated at 84.3x.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for RGEN.
Grade D
42
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| RGEN Target | Repligen Corp. | $7.9B | 133.8x | 84.1x | 1.8% | N/A | N/A | N/A | -0.3x | N/A |
| AVTR | Avantor arinc. | $8.6B | -10.4x | 24.6x | -5.6% | 0.5% | 7.6% | 32.7% | N/A | N/A |
| TFX | TELEFLEX INCORPORATED | $5.5B | -6.6x | 5362.4x | -15.7% | -4.7% | 0.1% | 56.2% | 13.0x | N/A |
| SOLV | Solventum Corp | $11.6B | 8.7x | -1572.9x | 15.4% | N/A | -0.1% | 53.5% | 1.6x | N/A |
| HOLX | Hologic Inc. | $11.8B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| ALGN | Align Technology Inc. | $13.0B | 29.0x | 24.3x | 10.1% | 10.3% | 12.2% | 67.2% | -1.4x | N/A |
| BLCO | Bausch + Lomb Corp | $4.0B | -15.6x | -131.6x | -3.1% | 8.4% | -1.3% | N/A | 16.9x | N/A |
| BAX | Baxter International Inc. | $15.6B | -10.3x | 69.5x | -6.1% | -0.7% | 3.0% | 30.1% | 11.1x | N/A |
| COO | Cooper Cos Inc | $16.3B | 33.4x | 37.4x | 4.6% | 11.0% | 10.6% | 65.5% | -0.1x | N/A |
Financial Charts
No financial data available for RGEN (annual).
2 superinvestors own RGEN
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Lee Ainslie Maverick Capital | 1,518,805 | $179M | 2.08% | 0.0% |
| Wallace Weitz Weitz Large Cap Equity Fund | 25,500 | $3M | 0.21% | 0.0% |